GEO observational study: 24 months characteristics of socioeconomic and clinical status in schizophrenia patients treated with olanzapine and haloperidol in Germany

被引：0
|
作者：
Eichmann, F
Reitberger, U
Clouth, J
Czekalla, J
机构：
[1] Kendle GmbH & Co GMI KG, Munich, Germany
[2] Lilly Deutschland GmbH, Bad Homburg, Germany
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)67770-4
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A203 / A203
页数：1
相关论文
共 50 条
  • [1] GEO observational study: 12 month's disease characteristics, side effects and socioeconomic status in schizophrenia patients treated with olanzapine and haloperidol in Germany
    Eichmann, FRW
    Reitberger, U
    Clouth, J
    Salize, HJ
    VALUE IN HEALTH, 2004, 7 (06) : 776 - 776
  • [2] Patient and disease characteristics in schizophrenia outpatients and inpatients treated with olanzapine and haloperidol in Germany: Results from the GEO observational study
    Eichmann, F
    Reitberger, U
    Spannheimer, A
    Lothgren, M
    Clouth, J
    Naber, D
    VALUE IN HEALTH, 2002, 5 (06) : 518 - 519
  • [3] Antipsychotic medication patterns in schizophrenia outpatients and inpatients treated with olanzapine and haloperidol in Germany: Results from the GEO observational study
    Eichmann, F
    Reitberger, U
    Spannheimer, A
    Lothgren, M
    Clouth, J
    Naber, D
    VALUE IN HEALTH, 2002, 5 (06) : 518 - 518
  • [4] IMPACT OF DISEASE SEVERITY ON DURATION OF HOSPITALIZATION IN PATIENTS WITH SCHIZOPHRENIA TREATED WITH OLANZAPINE OR HALOPERIDOL IN GERMANY: POST-HOC ANALYSIS OF DATA COLLECTED IN THE GEO STUDY
    Clouth, J.
    Schmidt, P.
    Moeser, G.
    Eichmann, F.
    Breitscheidel, L.
    VALUE IN HEALTH, 2009, 12 (07) : A354 - A354
  • [5] Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol:: results of the EIRE study
    Bobes, J
    Rejas, J
    Garcia-Garcia, M
    Rico-Villademoros, F
    García-Portilla, MP
    Fernández, I
    Hernández, G
    SCHIZOPHRENIA RESEARCH, 2003, 62 (1-2) : 77 - 88
  • [6] EFFECTIVENESS OF LONG-ACTING INJECTABLE RISPERIDONE AND ORAL ATYPICAL ANTIPSYCHOTICS IN A 24-MONTHS OBSERVATIONAL STUDY IN ADULT PATIENTS WITH SCHIZOPHRENIA IN GERMANY
    Hargarter, L.
    Fleischmann, J.
    Diels, J.
    Rabinowitz, J.
    Hemels, M.
    Gaudig, M.
    Van Sanden, S.
    Schreiner, A.
    VALUE IN HEALTH, 2011, 14 (07) : A287 - A287
  • [7] An observational study (IC-SOHO) comparing olanzapine, risperidone, quetiapine, and haloperidol in the treatment of patients with schizophrenia:: 12-month results
    Treuer, T
    Bartiene, R
    Blinc-Pesek, M
    Grigoriu, A
    Herman, E
    Molnár, B
    Pecenak, J
    Shakhnovich, T
    Szulc, A
    Leadbetter, J
    O'Mahoney, J
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S271 - S272
  • [8] Long-Term Antipsychotic Monotherapy for Schizophrenia: Disease Burden and Comparative Outcomes for Patients Treated With Olanzapine, Quetiapine, Risperidone, or Haloperidol Monotherapy in a Pan-Continental Observational Study
    Dossenbach, Martin
    Pecenak, Jan
    Szulc, Agata
    Irimia, Victoria
    Anders, Martin
    Logozar-Perkovic, Dusanka
    Peciukaitiene, Dalia
    Kotler, Moshe
    Smulevich, Anatoly B.
    West, Teena M.
    Lowry, Amanda J.
    Treuer, Tamas
    JOURNAL OF CLINICAL PSYCHIATRY, 2008, 69 (12) : 1901 - 1915
  • [9] Frequency of sexual dysfunction and other reproductive side-effects in patients with schizophrenia treated with risperidone, olanzapine, quetiapine, or haloperidol:: The results of the EIRE study
    Bobes, J
    García-Portilla, MP
    Rejas, J
    Hernández, G
    Garcia-Garcia, M
    Rico-Villademoros, F
    Porras, A
    JOURNAL OF SEX & MARITAL THERAPY, 2003, 29 (02) : 125 - 147
  • [10] Subjective experience and D2 receptor occupancy in patients with schizophrenia, treated with low dose olanzapine or haloperidol;: A randomized double-blind study
    de Haan, L
    van Bruggen, M
    Lavalaye, J
    Booij, J
    Dingemans, P
    Linszen, D
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 179 - 180
12345